Показано 0 из 0
Дата |
---|
02.05.2024 |
30.04.2024 |
29.04.2024 |
26.04.2024 |
25.04.2024 |
24.04.2024 |
23.04.2024 |
22.04.2024 |
19.04.2024 |
18.04.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
8.35
|
8.60
|
8.40
|
8.25
|
8.40
|
8.25
|
|
|
|
|
8.45
|
8.80
|
8.25
|
8.25
|
8.50
|
8.50
|
|
|
|
|
8.30
|
8.60
|
8.45
|
8.40
|
8.55
|
8.40
|
|
|
|
|
8.45
|
8.80
|
8.40
|
8.35
|
8.45
|
8.45
|
|
|
|
|
8.35
|
8.75
|
8.20
|
8.20
|
8.45
|
8.45
|
|
|
|
|
8.35
|
8.65
|
8.40
|
8.30
|
8.40
|
8.30
|
|
|
|
|
8.50
|
8.80
|
8.55
|
8.45
|
8.75
|
8.45
|
|
|
|
|
8.70
|
9.05
|
8.50
|
8.50
|
8.60
|
8.60
|
|
|
|
|
8.50
|
8.85
|
8.85
|
8.60
|
8.85
|
8.60
|
|
|
|
|
8.80
|
9.15
|
8.85
|
8.75
|
8.85
|
8.75
|
|
|
|
|
Fennec Pharmaceuticals Inc., a biopharmaceutical company, develops product candidates for use in the treatment of cancer in the United States. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014.